Immunogenicitet Antistoffer rettet mod abataceptmolekylet vurderedes ved ELISA- analyse hos patienter med reumatoid artritis, der fik behandling med abatacept i op til 3 år.
Immunogenicity Antibodies directed against the abatacept molecule were assessed by ELISA assays in rheumatoid arthritis patients treated for up to 3 years with abatacept.